Поражения кожи, ассоциированные с новой коронавирусной инфекцией (COVID-19)


DOI: https://dx.doi.org/10.18565/pharmateca.2020.8.8-17

И.В. Кошелева (1, 3), О.А. Биткина (2), Л.И. Шадыжева (1), А.Ю. Николаева (2), О.В. Андрияхина (3), О.А. Панкова (2), Е.С. Удалова (2), А.А. Цыганова (2)

1) Российская медицинская академия непрерывного профессионального образования, Москва, Россия; 2) Приволжский исследовательский медицинский университет, Нижний Новгород, Россия; 3) АО «РЖД-ЗДОРОВЬЕ», Москва, Россия
В обзоре приведены подробные описания различных сыпей, ассоциированных с новой коронавирусной инфекцией
(COVID-19), возникающих у пациентов с лабораторно подтвержденным заболеванием, а также проанализирована диагностическая ценность высыпаний. Описаны особенности иммуносупрессивной терапии тяжелых хронических дерматозов на фоне коронавирусной инфекции. Обобщены подходы к нейтрализации негативных для кожи последствий постоянного использования средств индивидуальной защиты и опыт организации дерматологической службы на фоне пандемии COVID-19.
Ключевые слова: COVID-19, SARS-CoV-2, коронавирус, ветряная оспа, вирусная экзантема, ознобления, акро-ишемия, псориаз, атопический дерматит, циклоспорин, иммунобиологические препараты, гидроксихлорохин

Литература


1. Gupta G., Singh Y., Chellappan D.K., Dua K. New Emerging Dermatological Symptoms in Coronavirus Pandemic. J Cosmet Dermatol. 2020. PMID: 32365277. Doi: 10.1111/jocd.13466.


2. Kalner S., Vergilis I.J. Periorbital Erythema as a Presenting Sign of Covid-19. JAAD Case Rep. 2020. PMID: 32395600; PMCID: PMC7212975. Doi: 10.1016/j.jdcr.2020.05.001.


3. Castelnovo L., Capelli F., Tamburello A., et al. Symmetric Cutaneous Vasculitis in COVID-19 Pneumonia» J Eur Acad Dermatol. Venereol. 2020;PMID: 32378747. Doi: 10.1111/jdv.16589


4. Vanegas Ramirez A., Efe D., Fischer M. Drug-induced Vasculitis in a Patient With COVID-19. J Eur Acad Dermatol Venereol. 2020. PMID: 32378770. Doi: 10.1111/jdv.16588.


5. Marzano A.V., Genovese G., Fabbrocini G., et al. Varicella-like Exanthem as a Specific COVID-19-associated Skin Manifestation: Multicenter Case Series of 22 Patients. J Am Acad Dermatol. 2020;S0190-9622(20)30657-5. PMID: 32305439. Doi: 10.1016/j.jaad.2020.04.044,


6. Ortega-Quijano D., Jimenez-Cauhe J., Burgos-Blasco P., et al. Reply to «Varicella-like Exanthem as a Specific COVID-19-associated Skin Manifestation: Multicenter Case Series of 22 Patients»: Discussing Specificity. J Am Acad Dermatol. 2020;S0190-9622(20)30778-7. PMID: 32380215; PMCID: PMC7198135. Doi: 10.1016/j.jaad.2020.04.156


7. Fernandez-Nieto D., Ortega-Quijano D., Jimenez-Cauhe J., et al. Clinical and Histological Characterization of Vesicular COVID-19 Rashes: A Prospective Study in a Tertiary Care Hospital. Clin Exp Dermatol. 2020 May 8;10.1111/ced.14277. PMID: 32384180; PMCID: PMC7273083. Doi: 10.1111/ced.14277.


8. Morey-Olivé M., Espiau M., Mercadal-Hally M., et al. Cutaneous Manifestations in the Current Pandemic of Coronavirus Infection Disease (COVID 2019)». Pediat (Barc). 2020 Apr 17;S1695-4033(20)30165-X. PMID: 32389502; PMCID: PMC7164857. Doi: 10.1016/j.anpedi.2020.04.013.


9. De Masson A., Bouaziz J.-D., Sulimovic L., et al. Chilblains Are a Common Cutaneous Finding During the COVID-19 Pandemic: A Retrospective Nationwide Study From France. J Am Acad Dermatol. 2020 May 4;S0190-9622(20)30789-1. PMID: 32380219; PMCID: PMC7198162. Doi: 10.1016/j.jaad.2020.04.161.


10. Suarez-Valle A., Fernandez-Nieto D., Diaz-Guimaraens B. Acro-ischemia in Hospitalized COVID-19 Patients. J Eur Acad Dermatol. Venereol. 2020 May 7;PMID: 32378743. Doi: 10.1111/jdv.16592.


11. Saenz Aguirre A., De la Torre Gomar F.J., Rosés-Gibert P., et al. Novel Outbreak of Acral Lesions in Times of COVID-19: A Description of 74 Cases From a Tertiary University Hospital in Spain. Clin Exp Dermatol. 2020 May 18;10.1111/ced.14294. PMID: 32421857; PMCID: PMC7276798. Doi: 10.1111/ced.14294.


12. Piccolo V., Bassi A. Acral Findings During the COVID-19 Outbreak: Chilblain-like Lesions Should Be Preferred to Acro-Ischemic Lesions. J Am Acad Dermatol. 2020 May 21;S0190-9622(20)30946-4. PMID: 32446827; PMCID: PMC7242179. Doi: 10.1016/j.jaad.2020.05.077.


13. Fernandez-Nieto D., Jimenez-Cauhe J., Suarez-Valle A., et al. Comment On: «Acral Findings During the COVID-19 Outbreak: Chilblain-like Lesions Should Be Preferred to Acro-Ischemic Lesions. J Am Acad Dermatol. 2020 May 21;S0190-9622(20)30947-6. PMID: 32446824; PMCID: PMC7241383. doi: 10.1016/j.jaad.2020.05.078.


14. Rivera-Oyola R., Koschitzky M., Printy R., et al. Dermatologic Findings in Two Patients With COVID-19. JAAD Case Rep. 2020 Apr 28;PMID: 32346588; PMCID: PMC7187826. Doi: 10.1016/j.jdcr.2020.04.027.


15. Cepeda-Valdes R., Carrion-Alvarez D., Trejo-Castro A., et al. Cutaneous Manifestations in COVID-19: Family Cluster of Urticarial Rash. Clin Exp Dermatol. 2020 May 14;PMID: 32407564. Doi: 10.1111/ced.14290 18.


16. Janah H., Zinebi A., Elbenaye J. Atypical Erythema Multiforme Palmar Plaques Lesions Due to Sars-Cov-2. J Eur Acad Dermatol Venereol. 2020 May 9;PMID: 32386446. Doi: 10.1111/jdv.16623.


17. De GiorgiV., Recalcati S., Jia Z., et al. Cutaneous Manifestations Related to Coronavirus Disease 2019 (COVID-19): A Prospective Study From China and Italy. J Am Acad Dermatol. 2020 May 19;S0190-9622(20)30941-5. PMID: 32442696; PMCID: PMC7235557. Doi: 10.1016/j.jaad.2020.05.073.


18. Skroza N., Bernardini N., Balduzzi V., et al. A Late Onset Widespread Skin Rash in a Previous Covid-19 Infected Patient: Viral or Multidrug Effect? J Eur Acad Dermatol Venereol. 2020 May 18;10.1111/jdv.16633. PMID: 32421877; PMCID: PMC7276891. doi: 10.1111/jdv.16633.


19. Wollina U., Serap Karadağ A., Rowland-Payne C., et al. Cutaneous Signs in COVID-19 Patients: A Review. Dermatol Ther. 2020 May 10;e13549; PMID: 32390279. Doi: 10.1111/dth.13549.


20. Duramaz B., Yozgat C.Y., Yozgat Y., et al. Appearance of Skin Rash in Pediatric Patients With COVID-19: Three Case Presentations. Dermatol Ther. 2020 May 15;e13594. PMID: 32412681; PMCID: PMC7261998. doi: 10.1111/dth.13594.


21. Jia J.L., Kamceva M., Rao S.A., Linos E. Cutaneous Manifestations of COVID-19: A Preliminary Review. J Am Acad Dermatol. 2020 May 15;S0190-9622(20)30924-5. PMID: 32422225; PMCID: PMC7229462. Doi: 10.1016/j.jaad.2020.05.059.


22. Young S., Fernandez A.P. Skin Manifestations of COVID-19. Cleveland Clinic. J Med. 2020 May 14. PMID: 32409442. Doi: 10.3949/ccjm.87a.ccc031.


23. Rudnicka L., Goldust M., Glowacka P., el al. Cyclosporine Therapy During the COVID-19 Pandemic Is Not a Reason for Concern. J Am Acad Dermatol. 2020 May 3;S0190-9622(20)30775-1. PMID: 32376422; PMCID: PMC7196541. Doi: 10.1016/j.jaad.2020.04.153.


24. Benhadou F., Del Marmol V. Improvement of SARS-CoV2 Symptoms Following Guselkumab Injection in a Psoriatic Patient. J Eur Acad Dermatol Venereol. 2020 May 7;PMID: 32379925. Doi: 10.1111/jdv.16590.


25. Conti A., Lasagni C., Bigi L., Pellacani G. Evolution of COVID-19 Infection in 4 Psoriatic Patients Treated With Biological Drugs. J Eur Acad Dermatol Venereol. 2020 May 7;PMID: 32379913. Doi: 10.1111/jdv.16587.


26. Di Lernia V., Bombonato C., Motolese A. COVID-19 in an Elderly Patient Treated With Secukinumab. Dermatol Ther. 2020 May 13;e13580. PMID: 32406078. Doi: 10.1111/dth.13580.


27. Shah M., Sachdeva M., Alavi A., et al. Optimizing Care for Atopic Dermatitis Patients During COVID-19 Pandemic. J Am Acad Dermatol. 2020 May 13;PMID: 32405123; PMCID: PMC7217788. Doi: 10.1016/j.jaad.2020.05.027.


28. Ferrucci S., Romagnuolo M., Angileri L., et al. Safety of Dupilumab in Severe Atopic Dermatitis and Infection of Covid-19: Two Case Reports. J Eur Acad Dermatol Venereol. 2020 Apr 24;PMID: 32330323. Doi: 10.1111/jdv.16527.


29. Patruno C., Nisticò S.P., Fabbrocini G., Napolitano M. COVID-19, Quarantine, and Atopic Dermatitis. Med. Hypotheses. 2020 May 19;143:109852. PMID: 32447099; PMCID: PMC7236680. Doi: 10.1016/j.mehy.2020.109852.


30. Sachdeva M., Mufti A., MaliyarK., et al. Hydroxychloroquine Effects on Psoriasis: A Systematic Review and a Cautionary Note for COVID-19 Treatment. J Am Acad Dermatol. 2020 May 19;S0190-9622(20)30942-7. PMID: 32442699; PMCID: PMC7235574. Doi: 10.1016/j.jaad.2020.05.074.


31. Litaiem N., Hajlaoui K., Karray M., et al. Acute Generalized Exanthematous Pustulosis After COVID-19 Treatment With Hydroxychloroquine. Dermatol. Ther. 2020 May 13;e13565; PMID: 32401410; PMCID: PMC7261985. Doi: 10.1111/dth.13565.


32. Abtahi-Naeini B. Frequent Handwashing Amidst the COVID-19 Outbreak: Prevention of Hand Irritant Contact Dermatitis and Other Considerations. Health Sci Rep. 2020;3(2):e163. PMID: 32346616; PMCID: PMC7185953. Doi: 10.1002/hsr2.163.


33. Maliyar K., Sachdeva M., Mufti A., Yeung J. Reply To: Skin Damage Among Healthcare Workers Managing Coronavirus disease-2019. J Am Acad Dermatol. 2020 May 14;S0190-9622(20)30868-9.


34. Blicharz L., Czuwara J., Samochocki Z., et al. Hand Eczema – A Growing Dermatological Concern During the COVID-19 Pandemic and Possible Treatments. Dermatol Ther. 2020 May 8;e13545. PMID: 32384196; PMCID: PMC7261986. Doi: 10.1111/dth.13545.


35. Dong L., Yang L., Li Y., et al. Efficacy of Hydrogel Patches in Preventing Facial Skin Damage Caused by Mask Compression in Fighting Against Coronavirus Disease 2019: A Short-Term, Self-Controlled Study. J Eur Acad Dermatol Venereol. 2020 May 18;10.1111/jdv.16638. PMID: 32421878; PMCID: PMC7276886. doi: 10.1111/jdv.16638.


36. Rismiller K., Cartron A.M., Trinidad J.C.L. Inpatient Teledermatology During the COVID-19 Pandemic. J. Dermatol. Treat. 2020 May 13;1–3. Doi: 10.1080/09546634.2020.1762843.


37. Freeman E.E., McMahon D.E., Fitzgerald M.E., et al. The AAD COVID-19 Registry: Crowdsourcing Dermatology in the Age of COVID-19. J Am Acad Dermatol. 2020 Apr 16;S0190-9622(20)30658-7. PMID: 32305438. Doi: 10.1016/j.jaad.2020.04.045.


38. Nazzaro G., Marzano A.V., Berti E. What Is the Role of a Dermatologist in the Battle Against COVID-19? The Experience From a Hospital on the Frontline in Milan. Int J Dermatol. 2020 May 7;PMID: 32378731. Doi: 10.1111/ijd.14926.


39. Al-Niaimi F., Ali F.R. COVID-19 and Dermatologic Surgery: Hazards of Surgical Plume. Dermatol Ther. 2020 May 15;e13593. PMID: 32412689; PMCID: PMC7262016. Doi: 10.1111/dth.13593.


40. Damevska K., Neloska L., Simeonovski V., et al. Impact of COVID-19 Outbreak on Dermatology Services: Dermatology in Isolation. Dermatol Ther. 2020 May 10;e13552. PMID: 32390176. Doi: 10.1111/dth.13552.


41. Cerro P.A., Palma A.M., Navarro-Bielsa A., et al. RF-Organisation of a Dermatology Department During the COVID-19 Pandemic. Actas Dermosifiliogr. 2020 Apr 24;S0001-7310(20)30106-X. PMID: 32389322; PMCID: PMC7181984. Doi: 10.1016/j.ad.2020.04.003.


42. Loh T.Y., Hsiao J.L., Shi V.Y. COVID-19 and Its Impact on Medical Student Education in Dermatology. J Am Acad Dermatol. 2020 May 12;S0190-9622(20)30857-4. PMID: 32413448; PMCID: PMC7252068. Doi: 10.1016/j.jaad.2020.05.026.


43. Muzumdar S., Grant-Kels J.M., Feng H. Dear Dermatoethicist: Web-Based Dermatology Residency Interviews in the Time of COVID-19. J Am Acad Dermatol. 2020 May 12;S0190-9622(20)30856-2. PMID: 32413445; PMCID: PMC7217072. Doi: 10.1016/j.jaad.2020.05.025.


44. Arora G., Jafferany M., Arora S. Balancing Aesthetic and Conventional Dermatology Practice in the COVID-19 Era. Dermatol Ther. 2020 May 19;e13620. PMID: 32431094. Doi: 10.1111/dth.13620.


Об авторах / Для корреспонденции


Автор для связи: О.А. Биткина, д.м.н., профессор кафедры кожных и венерических болезней, Приволжский исследовательский медицинский университет, Нижний Новгород, Россия; e-mail: oksana381@yandex.ru
Адрес: 603005, Россия, Н. Новгород, пл. Минина и Пожарского, 10/1


Бионика Медиа